Medical Devices and the FDA: Series Spanning Key Topics

Boston, MA

Medical device startups, are you challenged to understand the Food and Drug Administration’s (FDA) regulatory rules? Are you unsure of your product’s proper class and approval process? Will you be able to obtain proper clearance? Do you know how to obtain an IRB and work with an external medical facility? How about the best strategy...

EM Biotech Connect 2022

Boston, MA

Apply today! Elemental Machines is hosting a two-day event on September 21-22 at MassBioHub in Boston, MA. These in-person events bring together the life science lab operations ecosystem with trusted industry partners to foster conversations among the brightest minds defining the future labs through digital transformation, operational excellence, and leadership development. Join us to contribute...

i2b2 tranSMART 2022 Harvard Symposium

Boston, MA

We are pleased to announce the  i2b2 tranSMART 2022 Harvard Symposium will be a live event in Boston, September 19-20! This annual event brings together academic, industry and government clinicians, scientists and technologies who share the experience of using i2b2 and/or tranSMART from across the US, Europe, and beyond.  The two day meeting includes speakers...

Wells Fargo Securities Healthcare Conference

Boston, MA

2022 Wells Fargo Healthcare Conference September 7 - 9, 2022, Encore Boston Harbor , Everett, Massachusetts Conference Coordinator: Deirdre Gilfeather

Operationalize: Decentralized Clinical Trials Summit

Boston, MA

Your Practical Guide to Planning & Running Patient-Centric Decentralized Clinical Trials (DCTs) We all know that decentralized clinical trials offer a plethora of advantages to trial participants and sponsors. What we don’t know is how to simplify regulatory understanding, streamline internal protocols, restructure recruitment processes, improve patient communication and address all the other operational challenges...

Optimizing AAV Safety Summit

Boston, MA

Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development. Given the sheer volume of studies in the pipeline, the need to administer high doses, the clinical holds placed on gene therapy trials, and regulatory bodies being increasingly stringent on the safety standards they require; it has never been more...

2nd Integrin-Targeted Drug Development Summit

Boston, MA

Over the last 12 months, the integrins industry has witnessed promising data and clinical updates: 7 Hills Pharma’s new study demonstrated integrin activation can bring the heat to cold melanoma tumors and received the FDA’s Fast Track and Orphan Drug designation Caladrius Biosciences and Cend Therapeutics presented their  alpha-v integrins PhIb/IIa trial data in pancreatic, colorectal and appendiceal...

Canaccord Genuity Annual Growth Conference

Boston, MA

Join us in person for this annual event which brings together institutional investors from across the globe with some of the best and most promising growth companies in our core sectors - Technology, Healthcare & Life Sciences, Sustainability, Industrials, and Consumer & Retail.